iSpecimen Inc
For the period ended Jun 30, 2024. Filed Aug 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 6, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 5. Other Information
Board Committees
On July 19, 2024, the Board of Directors of the Company approved the following composition of each standing committee of the Board of Directors:
| Committee | Chair | Members |
|---|---|---|
| Audit Committee | John L. Brooks III | John L. Brooks III, Elizabeth Graham and Steven Gullans |
| Compensation Committee | Steven Gullans | Steven Gullans, John L. Brooks III and Theresa L. Mock |
| Nominating and Corporate Governance Committee | Theresa L. Mock | Theresa L. Mock and Elizabeth Graham |
Trading Arrangements
During the quarterly period ended June 30, 2024, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10 b5-1 trading arrangement” or any “non-Rule 10 b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Departure of Officer
In the Company’s Current Report on Form 8-K filed with the SEC on July 8, 2024, the Company reported the resignation of Benjamin Bielak, as Chief Information Officer and Secretary of the Company. Mr. Bielak also performed the functions of Chief Information Security Officer in connection with various security matters relating to the Company’s operations, including cybersecurity matters. As a result of his resignation, the remaining members of the Company’s Risk Management Committee, including the Company’s Chief Executive Officer, oversee this function.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.